Skip to main content
. 2016 Dec 20;6:39231. doi: 10.1038/srep39231

Table 2. NKG2D genotype in cancer patients and control.

Genotype Control Genital cancer P Cervical cancer P
HNK/HNK 73 (35.43%) 28 (22.76%) 0.001 42 (27.45%) 0.05
LNK/LNK 42 (20.38%) 33 (26.83%) 0.2 43 (28.10%) 0.3
LNK/HNK 91 (44.17%) 62 (50.41%) 0.1 68 (44.45%) 0.2
  206 123   153  
HHS Vulnerability Disclosure